SBC Medical | 8-K: FY2025 Q3 Revenue: USD 43.35 M

LB filings
2025.11.14 11:52
portai
I'm PortAI, I can summarize articles.

Revenue: As of FY2025 Q3, the actual value is USD 43.35 M.

EPS: As of FY2025 Q3, the actual value is USD 0.12.

EBIT: As of FY2025 Q3, the actual value is USD 15.81 M.

Financial Metrics by Segment

Segment Revenue

  • Franchising revenue decreased by 37% to $10 million in 3Q25 from $16 million in 3Q24. Year-to-date (YTD) franchising revenue was $36 million, down 22% from $45 million in 3Q24.
  • Procurement revenue fell by 24% to $13 million in 3Q25 from $18 million in 3Q24. YTD procurement revenue was $43 million, a slight decrease of 2% from $44 million in 3Q24.
  • Management services revenue decreased by 22% to $9 million in 3Q25 from $12 million in 3Q24. YTD management services revenue was $23 million, a 48% decline from $44 million in 3Q24.
  • Rental services revenue increased by 51% to $6 million in 3Q25 from $4 million in 3Q24. YTD rental services revenue was $19 million, a 67% increase from $11 million in 3Q24.

Operational Metrics

  • Gross profit for 3Q25 was $31 million, a decrease of 29% from $43 million in 3Q24. YTD gross profit was $98 million, down 19% from $122 million in 3Q24.
  • Operating expenses for 3Q25 were $15 million, a 50% decrease from $29 million in 3Q24. YTD operating expenses were $44 million, a 23% decrease from $57 million in 3Q24.
  • Income from operations for 3Q25 was $16 million, a 15% increase from $14 million in 3Q24. YTD income from operations was $55 million, a 17% decrease from $66 million in 3Q24.
  • Net income attributable to SBC Medical Group Holdings Incorporated for 3Q25 was $13 million, a 353% increase from $3 million in 3Q24. YTD net income was $37 million, an 8% decrease from $40 million in 3Q24.

Cash Flow

  • Net cash used in operating activities for 3Q25 YTD was -$27 million, compared to $28 million provided in 3Q24 YTD.
  • Net cash provided by investing activities for 3Q25 YTD was $3 million, compared to -$6 million used in 3Q24 YTD.
  • Net cash provided by financing activities for 3Q25 YTD was $18 million, a 59% increase from $12 million in 3Q24 YTD.

Unique Metrics

  • The average revenue per visit in 3Q25 was $298, a 5% decrease from the previous year.

Outlook / Guidance

  • SBC Medical Group Holdings Incorporated anticipates continued growth in its network of locations and customer base, aiming for further expansion both domestically and overseas. The company is optimizing pricing and promotion strategies to drive higher revenue per customer visit through multi-branding efforts. Additionally, SBC Medical Group Holdings Incorporated is expanding into the Thai aesthetic medical market, leveraging its strong Japanese brand presence and strategic partnerships.
Source: LB filings The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.